Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-43 is a gene segment encoding the **variable domain** of the heavy chain in human immunoglobulins (antibodies)[1]. The protein, part of the immunoglobulin superfamily, contributes to antigen recognition by forming part of the antigen-binding site of antibodies, in conjunction with associated light chain variable domains[3]. The variable regions are generated through V-(D)-J recombination and provide the molecular diversity required for the adaptive humoral immune response[1][3]. The structure allows for high affinity binding to specific antigens, initiating B cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells[1][3]. IGHV3-43 is one among many IGHV germline gene segments, and the usage—or mutation status—of IGHV genes (in general, not specifically IGHV3-43) can serve as a diagnostic and prognostic biomarker in diseases such as chronic lymphocytic leukemia[2]. IGHV3-43 itself is not a typical direct therapeutic target (i.e., not a receptor, enzyme, or transporter), but rather a segment encoding antibody diversity for immune recognition[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-43 (IGHV3-43).